MPR et Covid 2
Le 15/10/2021 de 16:00 à 18:00
Prévalence et évaluation de la dysphagie oropharyngée secondaire à une pneumopathie a SARS-CoV2 en réanimation.
Clément Rossignol (Bois Guillaume, France), Rémi Mallart (Bois Guillaume, France), Eric Vérin (Bois Guillaume, France)
Objective : Oropharyngeal dysphagia (OPD) in intensive care is increasingly being studied in view of the increased risk of morbidity and mortality. The main objective of this study was therefore to evaluate the prevalence of dysphagia in ICU in patients with Covid-19.
Material / Patients and Methods : This study was a cohort, observational, retrospective study of patients admitted to the intensive care units at the Rouen University Hospital Centre in France, in the context of the SARS-Cov2 epidemic.
Results : Over 4 months, 122 patients were hospitalized in Intensive Care Units at Rouen University Hospital for SARS-Cov2 infection and 58 were intubated and ventilated in whom 43 were assessed. Associated with screening, the presence of post extubation dysphagia was found in 62.7% of intubated patients. In univariate analysis, there appeared to be a significant association between the presence of swallowing disorder and the severity of initial pathology (p=0.011), duration of orotracheal intubation (p<0.01), duration of curares (p<0.01), depth of muscle weakness (p=0.038) and initial CT severity (p=0.033). The presence of dysphagia was not significantly associated with the length of hospitalisation in intensive care. At the end of resuscitation, 22% of patients with dysphagia had a normal diet, 56% had an adapted per os diet and 22% still had exclusive tube feeding. No inhalation pneumopathy following intensive care management was reported.
Discussion - Conclusion : In conclusion, the prevalence of Covid-19-related OPD in ICU is high and should be assessed with a systematic screening to optimise nutritional management and reduce the risk of early complications.
Keywords : SARS-CoV2, COVID 19, Swallowing disorders, deglutition disorders, oropharyngeal dysphagia
Disclosure of interest : Aucun